PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.\', \'Institute for Cell Biology, Department of Immunology, University of Tübingen, 72076 Tübingen, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies\', University of Tübingen, 72076 Tübingen, Germany.\', \'Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076 Tübingen, Germany.\', \'Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.\', \'German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, 72076 Tübingen, Germany.\', \'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.\', \'Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and Robert Bosch Center for Tumor Diseases (RBCT), 70376 Stuttgart, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • eabf751710.1126/scitranslmed.abf7517
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 33723016
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
?:title
  • T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all